Ractigen Therapeutics
PrivateLast Round
Early Funding
Jul 29, 2026
Total Funding Raised
$78M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Ractigen Therapeutics is a clinical-stage pharmaceutical company creating first-in-class therapies designed to boost expression of therapeutic genes in diseased cells using RNA activation (RNAa) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ractigen Therapeutics Comparables
Compare Ractigen Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MiNA Therapeutics | 85% | |
| CAMP4 | 73% | |
| Shape Therapeutics | 72% | |
Ractigen Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 29, 2026 | ||||
| Series A Extension | Jan 27, 2022 | ||||
| Series A | Feb 10, 2021 |
Key People
Founding team and executive leadership
Ractigen Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Early Funding |
| Boyu Capital | Series A |
| Longmen Capital | Early Funding |
| Hillhouse Investment | Series A |
| Huimei Capital | Series A |
| CCB International | Series A |
| SDIC Venture Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
$31M raised from IDG Capital and others.
- Jan 20, 2026
Monthly visitors increased 256% MoM.
Ractigen Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ractigen Therapeutics's valuation, stock price, and market status.